Advanced Filters
noise

Tokyo and Other Japanese City, Japan Clinical Trials

A listing of Tokyo and Other Japanese City, Japan clinical trials actively recruiting patients volunteers.

Found 65,447 clinical trials
G Gali Dar, PhD

The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program

assessment of the musculoskeletal system will be performed twice a year, for three years of young dancers

11 - 20 years of age Female Phase N/A
X XUEFENG FANG

Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab

Evaluate the objective response rate (ORR) of AK104 combined with chemotherapy and cetuximab or bevacizumab in second-line treatment of MSS type advanced colorectal cancer

18 - 75 years of age All Phase 2
R Ruihua Xu, Professor

JSKN022 in Subjects With Advanced Malignant Solid Tumors

The goal of this clinical trial is to learn if drug JSKN022 is safe to treat patients with advanced malignant solid tumors. It will also learn about the pharmacokinetic/ pharmacodynamic profiles and preliminary antitumor activity of drug JSKN022.

18 years of age All Phase 1
R Roman-Ulrich Müller, Prof. MD

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease is the most common genetic cause of kidney failure. The only approved treatment for ADPKD - tolvaptan - is limited in its use by massive therapy-associated polyuria. This trial tests if the SGLT2-inhibitor dapagliflozin slows down the loss of kidney function in ADPKD.

18 - 60 years of age All Phase 3
A Amber Pereira, M.A.

Social Threat, Adolescent Relationships, and Suicidality Study

In recent years, adolescents are having higher rates of emotional health problems, such as suicidal thoughts and behaviors (STBs). The goal of this study is to learn about how teens' attention to different types of information relates to their real-world relationships and their emotional health. The investigators hope this study …

12 - 17 years of age Female Phase N/A
A Ayşe Naz Kalem Özgen, Asist. Dr.

Effectiveness of Telerehabilitation on Pelvic Floor Dysfunction at Postpartum Woman

These events are largely due to pelvic floor dysfunction that develops after pregnancy. Kegel exercises and core stabilisation exercises performed in the postpartum period are important in preventing pelvic floor dysfunction. However, considering the mother's adaptation process to both the baby and her new life in the postpartum period, there …

18 - 45 years of age Female Phase N/A
S Sonia Galletti

Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence

Benzodiazepines and related molecules are among the most prescribed psychotropic treatments in France and Europe. 13.4% of the French population had at least one reimbursement of benzodiazepines in 2015, which places France second in Europe. However, the chronic use of benzodiazepines is a source of numerous complications, particularly addictive. To …

18 - 65 years of age All Phase 2/3
M Mandy Binning

Verapamil for Neuroprotection in Stroke

The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery …

18 - 80 years of age All Phase 1
W Winnie Samy, RN, BN, MSc

Minimum Effective Local Anesthetic Volume for Ultrasound Guided Superior Trunk Block

The objective of this study is to identify the minimum effective dosage of a commonly used local anaesthetic drug "levobupivacaine" required to produce an effective ultrasound guided (USG) superior trunk block (STB) in at least 90% of patients for shoulder arthroscopic surgeries.

18 - 75 years of age All Phase N/A

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N2 only) non-squamous Non-Small Cell Lung Cancer (NSCLC) to neoadjuvant ATEZOLIZUMAB plus Carboplatin/nab Paclitaxel Atezolizumab is given as intravenous infusion at a fixed dose of 1200 mg, day …

18 years of age All Phase 2

Simplify language using AI